Title:
SALT OF GLP-1R AGONIST COMPOUND, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/011395
Kind Code:
A1
Abstract:
Disclosed are salts of a series of GLP-1R agonist compounds, a pharmaceutical composition containing same, and the use of the compounds in drugs for treating diseases such as diabetes.
Inventors:
WU JUNJUN (CN)
LU YINSUO (CN)
LIAN XIAOLEI (CN)
LI QINZE (CN)
LI SONG (CN)
LU YINSUO (CN)
LIAN XIAOLEI (CN)
LI QINZE (CN)
LI SONG (CN)
Application Number:
PCT/CN2022/109367
Publication Date:
February 09, 2023
Filing Date:
August 01, 2022
Export Citation:
Assignee:
SHENZHEN SALUBRIS PHARM CO LTD (CN)
International Classes:
C07D401/14; A61K31/444; A61K31/496; A61P3/10
Domestic Patent References:
| WO2021018023A1 | 2021-02-04 | |||
| WO2022111624A1 | 2022-06-02 |
Foreign References:
| CN110325530A | 2019-10-11 | |||
| CN112566637A | 2021-03-26 |
Other References:
LI ZENG, JIANG WANG, YU ZHOU, HONG LIU: "Lead compound optimization strategy (3) — structure modification strategies for improving water solubility", ACTA PHARMACEUTICA SINICA, YAOXUE XUEBAO, CN, vol. 49, no. 9, 31 December 2014 (2014-12-31), CN , pages 1238 - 1247, XP093031588, ISSN: 0513-4870, DOI: 10.16438/j.0513-4870.2014.09.013
Download PDF: